Myovant Sciences Ltd (MYOV) Inventory Turnover Ratio, from third quarter 2023 to third quarter 2022, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Myovant Sciences Ltd   (NYSE: MYOV)
 

Myovant Sciences Ltd Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2023, Myovant Sciences Ltd 's inventory turnover ratio sequentially decreased to 1.02 in the third quarter 2022, unsurprisingly, as the Myovant Sciences Ltd markets continue to deteriorate, and MYOV's faces growing challenges to bring down its inventories. Myovant Sciences Ltd 's average inventory processing period in the Dec 31 2022 quarter, has increased to 358 days, from 302 days, in the Sep 30 2022 quarter.

Within Healthcare sector 377 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1594 in the second quarter 2022, to 1760.

MYOV Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Myovant Sciences Ltd Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MYOV Inventory Turnover Ratio (Dec 31 2022)
III. Quarter		 (Sep 30 2022)
II. Quarter		 (Jun 30 2022)
I. Quarter		 (Mar 31 2022)
IV. Quarter		 (Dec 31 2021)
III. Quarter
Y / Y Inventory Growth 346.55 % 275.3 % 408.68 % 190.46 % -
Y / Y Cost of Sales Growth 74.83 % 88.48 % 376.26 % 1100.33 % -
Inventory Turnover Ratio (TTM) 1.02 1.21 1.48 1.87 1.67
MYOV's Total Ranking # 1760 # 1594 # 1452 # 1755 # 1840
Average inventory processing period 358 302 247 195 219
Seq. Inventory Growth 30.53 % 8.6 % 179.83 % 12.57 % 9.71 %
Seq. Cost of Sales Growth 50.1 % 0.55 % 36.04 % -14.85 % 61.82 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 120
Healthcare Sector # 378
Overall Market # 1760

Inventory Turnover Ratio Statistics
High Average Low
1.87 1.45 1.02
(Mar 31 2022)   (Dec 31 2022)



MYOV Company Profile >> Back to MYOV Efficiency Comparisons >> Compare MYOV Inventory Turnover Ratio to its Competitors

Financial Statements
Myovant Sciences Ltd 's Inventories $ 30 Millions Visit MYOV's Balance sheet
Myovant Sciences Ltd 's Cost of Revenues TTM $ 21 Millions Visit MYOV's Income Statement
What are MYOV's Sales? Visit MYOV's Sales by Segment

Other Inventory Turnover Ratios
Myovant Sciences Ltd 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
MYOV's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for MYOV's Competitors
Inventory Turnover Ratio for MYOV's Suppliers
Inventory Turnover Ratio for MYOV's Customers

You may also want to know
MYOV's Sales Growth Rates MYOV's Pe Price to earnings ratio MYOV's Receivables Turnover Ratio MYOV's Stock Quote
MYOV's Net Income Growth Rates MYOV's Ps Price to Sales ratio MYOV's Sales per Employee MYOV's Asset Turnover Ratio
MYOV's Net Margin MYOV's Pb Price to Book ratio MYOV's Financial Strength Ratios MYOV's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Dec 31 2022, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Dec 31 2022 Inventories at quarter ending Dec 31 2022
Exelixis Inc   1.91 $ 57.909  Millions$ 30  Millions
Harvard Bioscience Inc   1.90 $ 52.516  Millions$ 28  Millions
Surmodics Inc   1.88 $ 21.112  Millions$ 11  Millions
Surgalign Holdings Inc   1.88 $ 41.691  Millions$ 22  Millions
Amicus Therapeutics inc   1.88 $ 38.599  Millions$ 21  Millions
Creative Medical Technology Holdings Inc   1.87 $ 0.028  Millions$ 0  Millions
Athenex Inc   1.87 $ 76.584  Millions$ 41  Millions
Atrion Corporation  1.86 $ 107.602  Millions$ 58  Millions
Encision Inc   1.86 $ 3.324  Millions$ 2  Millions
Meridian Bioscience Inc   1.86 $ 130.877  Millions$ 70  Millions
Bio rad Laboratories Inc   1.85 $ 1,234.919  Millions$ 667  Millions
Aurinia Pharmaceuticals Inc   1.84 $ 5.664  Millions$ 3  Millions
Integra Lifesciences Holdings Corp  1.83 $ 587.355  Millions$ 321  Millions
Gelesis Holdings Inc   1.83 $ 27.558  Millions$ 15  Millions
Accuray Incorporated  1.82 $ 261.692  Millions$ 144  Millions
Stryker Corp  1.81 $ 6,871.000  Millions$ 3,788  Millions
Nature s Sunshine Products inc   1.81 $ 122.150  Millions$ 68  Millions
Cardiovascular Systems Inc   1.81 $ 66.218  Millions$ 37  Millions
Establishment Labs Holdings Inc   1.79 $ 55.105  Millions$ 31  Millions
Accelerate Diagnostics Inc   1.77 $ 9.449  Millions$ 5  Millions
Eagle Pharmaceuticals inc   1.76 $ 85.458  Millions$ 49  Millions
Acadia Pharmaceuticals Inc   1.74 $ 10.166  Millions$ 6  Millions
Biogen Inc   1.74 $ 2,278.300  Millions$ 1,307  Millions
Yunhong Green Cti Ltd   1.74 $ 14.910  Millions$ 9  Millions
Ligand Pharmaceuticals Incorporated  1.71 $ 36.673  Millions$ 22  Millions
Anika Therapeutics Inc   1.70 $ 62.660  Millions$ 37  Millions
Pressure Biosciences Inc   1.68 $ 2.014  Millions$ 1  Millions
Therapeutic Solutions International Inc   1.68 $ 0.079  Millions$ 0  Millions
Alpha Pro Tech Ltd   1.67 $ 40.298  Millions$ 24  Millions
Eli Lilly And Company  1.66 $ 6,629.800  Millions$ 3,983  Millions

Date modified: 2026-08-29T17:37:43+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.